Nurse-led efforts to provide patients with ongoing lifestyle advice, education, and other resources reduced MACE by 30%.

While inconsistent dosing could have played a role, it still may be possible to identify the patients most likely to see ...

Disappointment over a cardiology board, an FDA approval, meeting news, and advice for practice—it’s all here this month.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

LV thrombus is less of an issue now thanks to primary PCI and antithrombotics, but it still occurs in 9% of anterior MIs.

Mamas Mamas, Stefan Anker, and Volker Rudolph talk about their studies of MitraClip for functional MR in patients with heart ...

Liberal fluid intake was safe and suggestive of better health status: this should be enough to stop restricting patients to 1 ...

Additional research is needed to determine whether this is due to direct drug effects or underlying patient factors.

The prothrombin complex concentrate costs more than plasma, but may pay dividends by way of fewer adverse events.